Senate Drug Pricing Hearing Looms As Unparalleled Event For Pharma
Executive Summary
From Vioxx to EpiPen, industry has been called in to testify before Congress on a range of issues. But with seven big pharma leaders having accepted the Senate Finance Committee's invitation Feb. 26, the stage is set for some exceptional political theater.
You may also be interested in...
Pharma Tweeting: Five Twitter Moments That Highlight The Perils Of The Platform
Scrip takes a broad look at some controversial Twitter moments that pharma should be watchful of - words once let out of the cage cannot be whistled back again.
Big Pharma Defuses Drug Pricing Landmines On Capitol Hill
Industry's top leaders weren't exactly eager to testify on Capitol Hill. Now they might be wondering why they waited so long. Seven pharma leaders avoided missteps during a Senate Finance Committee hearing on drug pricing Feb. 26.
Big Pharma Defuses Drug Pricing Landmines On Capitol Hill
Industry's top leaders weren't exactly eager to testify on Capitol Hill. Now they might be wondering why they waited so long. Seven pharma leaders avoided missteps during a Senate Finance Committee hearing on drug pricing Feb. 26.